ArisGlobal Expands its Safety Leadership Team with Industry Expertise

May 2, 2016

Dr. Vivek Ahuja, George Phillips and Stephen Schmidt Join the Growing Organization

APRIL 28, 2016 — ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, today announced key new leaders have joined the Safety and Pharmacovigilance team to bring a wealth of insight to a growing business.  This will bolster the company’s safety business unit with unparalleled pharmacovigilance knowledge.

George Phillips joined ArisGlobal in the position of Vice President – Safety.  George has over 30 years’ experience in pharmacovigilance.  George worked for UCB Inc.  where he held the position of Vice President, Digital Safety Surveillance. George has held various positions within pharmacovigilance with Bristol-Myers Squibb, GlaxoSmithKline, Parke-Davis and Procter & Gamble Pharmaceuticals. George is a registered pharmacist and received his B.S. and Pharm.D. Degrees from Purdue University in West Lafayette, Indiana.

ArisGlobal has created the National Competent Authorities (NCA) to address the needs of health authorities. Dr. Vivek Ahuja will lead this initiative as the Vice President – Global Pharmacovigilance.  Dr. Ahuja was Director, Research and Development at PATH India. He co-authored the Pharmacovigilance Program of India (Ministry of Health & Family Welfare, Government of India). Dr. Ahuja is a Bachelor of Medicine and Bachelor of Surgery (MBBS) from Government Medical College, Chandigarh, India and an MD from All India Institute of Medical Sciences, New Delhi. 

Stephen Schmidt has joined as the Product Manager – Safety.  Before joining ArisGlobal, Stephen was a Senior Safety Systems Analyst within the Medical Safety department at Alcon.  Stephen served as the Divisional E2B Coordinator, Business Functional Lead, Validation Team Lead, System Support and Subject Matter Expert for Safety Systems.  Stephen’s career in the pharmaceutical/medical device industry began in 1996.

“ArisGlobal has been a leader in Safety and Pharmacovigilance for years,” noted Sonia Veluchamy, Managing Director, “but the introduction of this leadership and knowledge will position ArisGlobal for exciting new growth and industry insight.  This is a bold new step into our increasingly bright future.”



About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn:
Follow @Aris_Global on Twitter:


Erika Thomas
+305-726-6601 |